Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1996-10-23
|
pubmed:abstractText |
Adolescents with conduct disorder and substance use disorders have high rates of comorbid attention-deficit hyperactivity disorder (ADHD); ADHD may contribute to the severity and persistence of substance use disorders and antisocial behaviors. Treatment of ADHD may help patients utilize substance and other behaviorally focused treatment. Yet little is known about the response of ADHD symptoms to psychopharmacological intervention in substance-dependent delinquents.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0890-8567
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1018-24
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8755798-Adolescent,
pubmed-meshheading:8755798-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:8755798-Central Nervous System Stimulants,
pubmed-meshheading:8755798-Humans,
pubmed-meshheading:8755798-Juvenile Delinquency,
pubmed-meshheading:8755798-Male,
pubmed-meshheading:8755798-Patient Compliance,
pubmed-meshheading:8755798-Patient Satisfaction,
pubmed-meshheading:8755798-Pemoline,
pubmed-meshheading:8755798-Psychiatric Status Rating Scales
|
pubmed:year |
1996
|
pubmed:articleTitle |
An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
|
pubmed:affiliation |
Department of Psychiatry, University of Colorado School of Medicine, Denver 80262, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|